We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Orla Mining, FIGS and Compass Therapeutics
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 24, 2025 – Stocks in this week’s article are — like Orla Mining Ltd. (ORLA - Free Report) , FIGS, Inc. (FIGS - Free Report) and Compass Therapeutics, Inc. (CMPX - Free Report) .
2025's Top 3 Breakout Stocks for Active Traders: Don't Miss Out
An active investing strategy focuses on identifying breakout stocks within a specific price range. Sell if the price drops below the lower boundary and hold onto the stock for gains if it surpasses the upper boundary.
To that end, Orla Mining Ltd., FIGS, Inc. and Compass Therapeutics, Inc. have been selected as today’s breakout stocks.
Zeroing in on Breakout Stocks
To pick a breakout stock, calculate support and resistance levels. A support level is the lower bound for stock movements, while a resistance level refers to the maximum price it trades at within a considerable period.
In other words, the demand for a stock is at its lowest at its support level, which means that most traders are willing to sell it. The majority of traders are willing to go long on the stock at the resistance level, meaning they would like to add it to their portfolio. The key to identifying breakout stocks is to zero in on those on the verge of a breakout or those that have just broken above the resistance level.
Has a Genuine Breakout Occurred?
The primary risk associated with such a strategy is that the decision to buy an apparent breakout candidate has been incorrectly timed. When a stock moves above the resistance level, it should be a highly prized commodity for traders. However, whether such a breakout is genuine is another matter altogether.
For a bona fide breakout, the stock’s earlier resistance barrier should become its new support level. This only happens if the established trading channel is tested by observing long-term price trends. The strength of the support and resistance levels can be ascertained only through such a study. Despite the risk of misidentification, correctly identifying such stocks can yield considerable returns, even at a price that may not seem attractive at first glance.
These criteria narrow the universe of more than 6,853 stocks to only 12. Here are the top three stocks:
Orla Mining
Orla Mining acquires, explores and develops mineral properties, focusing on gold, silver, zinc, lead, and copper deposits. ORLA has an expected earnings growth rate of 212% for the current year. ORLA currently has a Zacks Rank #2.
FIGS
FIGS, with its subsidiary FIGS Canada, operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. FIGS has an expected earnings growth rate of 400% for the current year. FIGS currently has a Zacks Rank #1.
Compass Therapeutics
Compass Therapeutics is a clinical-stage oncology biopharmaceutical company that engages in the development of antibody-based therapeutics for various human diseases in the United States. CMPX has an expected earnings growth rate of 16.7% for the next quarter. CMPX currently has a Zacks Rank #2.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights include Orla Mining, FIGS and Compass Therapeutics
For Immediate Release
Chicago, IL – November 24, 2025 – Stocks in this week’s article are — like Orla Mining Ltd. (ORLA - Free Report) , FIGS, Inc. (FIGS - Free Report) and Compass Therapeutics, Inc. (CMPX - Free Report) .
2025's Top 3 Breakout Stocks for Active Traders: Don't Miss Out
An active investing strategy focuses on identifying breakout stocks within a specific price range. Sell if the price drops below the lower boundary and hold onto the stock for gains if it surpasses the upper boundary.
To that end, Orla Mining Ltd., FIGS, Inc. and Compass Therapeutics, Inc. have been selected as today’s breakout stocks.
Zeroing in on Breakout Stocks
To pick a breakout stock, calculate support and resistance levels. A support level is the lower bound for stock movements, while a resistance level refers to the maximum price it trades at within a considerable period.
In other words, the demand for a stock is at its lowest at its support level, which means that most traders are willing to sell it. The majority of traders are willing to go long on the stock at the resistance level, meaning they would like to add it to their portfolio. The key to identifying breakout stocks is to zero in on those on the verge of a breakout or those that have just broken above the resistance level.
Has a Genuine Breakout Occurred?
The primary risk associated with such a strategy is that the decision to buy an apparent breakout candidate has been incorrectly timed. When a stock moves above the resistance level, it should be a highly prized commodity for traders. However, whether such a breakout is genuine is another matter altogether.
For a bona fide breakout, the stock’s earlier resistance barrier should become its new support level. This only happens if the established trading channel is tested by observing long-term price trends. The strength of the support and resistance levels can be ascertained only through such a study. Despite the risk of misidentification, correctly identifying such stocks can yield considerable returns, even at a price that may not seem attractive at first glance.
These criteria narrow the universe of more than 6,853 stocks to only 12. Here are the top three stocks:
Orla Mining
Orla Mining acquires, explores and develops mineral properties, focusing on gold, silver, zinc, lead, and copper deposits. ORLA has an expected earnings growth rate of 212% for the current year. ORLA currently has a Zacks Rank #2.
FIGS
FIGS, with its subsidiary FIGS Canada, operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. FIGS has an expected earnings growth rate of 400% for the current year. FIGS currently has a Zacks Rank #1.
Compass Therapeutics
Compass Therapeutics is a clinical-stage oncology biopharmaceutical company that engages in the development of antibody-based therapeutics for various human diseases in the United States. CMPX has an expected earnings growth rate of 16.7% for the next quarter. CMPX currently has a Zacks Rank #2.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at:
https://www.zacks.com/stock/news/2793897/2025s-top-3-breakout-stocks-for-active-traders-dont-miss-out
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.